Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seetal Dodd

Showing results (181-190 of 251) with videos related to

Pageof 26
Sort By:
Neuroscience and Biobehavioral Reviews|April 14, 2016
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesisJustin Davis, Harris Eyre, Felice N Jacka, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 10, 2023
Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?Samantha E Russell, Anna L Wrobel, Melanie M Ashton, et al.
Journal of Affective Disorders|July 17, 2013
Oxidative stress and lowered total antioxidant status are associated with a history of suicide attemptsHeber Odebrecht Vargas, Sandra Odebrecht Vargas Nunes, Marcia Pizzo de Castro, et al.
BMC Psychiatry|December 19, 2012
Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practiceJayashri Kulkarni, Sacha Filia, Lesley Berk, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 9, 2014
Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depressionOlivia M Dean, Alyna Turner, Gin S Malhi, et al.
Acta Neuropsychiatrica|March 9, 2016
Oxidative stress may be a common mechanism linking major depression and osteoporosisJulie A Pasco, Geoffrey C Nicholson, Felicity Ng, et al.
Comprehensive Psychiatry|August 24, 2010
A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorderSeetal Dodd, Alan J M Brnabic, Lesley Berk, et al.
Journal of Affective Disorders|August 18, 2012
The sick role, illness cognitions and outcomes in bipolar disorderMichael Berk, Lesley Berk, Seetal Dodd, et al.
Human Psychopharmacology|March 31, 2009
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trialMichael Berk, Clarissa S Gama, Suresh Sundram, et al.
Psychiatric Genetics|March 19, 2014
Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependenceSandra Odebrecht Vargas Nunes, Márcia Regina Pizzo de Castro, Maria Angelica Ehara Watanabe, et al.
Pageof 26

Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
Neuroscience and Biobehavioral Reviews|April 14, 2016
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesisJustin Davis, Harris Eyre, Felice N Jacka, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 10, 2023
Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?Samantha E Russell, Anna L Wrobel, Melanie M Ashton, et al.
Journal of Affective Disorders|July 17, 2013
Oxidative stress and lowered total antioxidant status are associated with a history of suicide attemptsHeber Odebrecht Vargas, Sandra Odebrecht Vargas Nunes, Marcia Pizzo de Castro, et al.
BMC Psychiatry|December 19, 2012
Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practiceJayashri Kulkarni, Sacha Filia, Lesley Berk, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 9, 2014
Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depressionOlivia M Dean, Alyna Turner, Gin S Malhi, et al.
Acta Neuropsychiatrica|March 9, 2016
Oxidative stress may be a common mechanism linking major depression and osteoporosisJulie A Pasco, Geoffrey C Nicholson, Felicity Ng, et al.
Comprehensive Psychiatry|August 24, 2010
A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorderSeetal Dodd, Alan J M Brnabic, Lesley Berk, et al.
Journal of Affective Disorders|August 18, 2012
The sick role, illness cognitions and outcomes in bipolar disorderMichael Berk, Lesley Berk, Seetal Dodd, et al.
Human Psychopharmacology|March 31, 2009
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trialMichael Berk, Clarissa S Gama, Suresh Sundram, et al.
Psychiatric Genetics|March 19, 2014
Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependenceSandra Odebrecht Vargas Nunes, Márcia Regina Pizzo de Castro, Maria Angelica Ehara Watanabe, et al.
Pageof 26